Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Jul 07
 +13.63 / +2.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 622.00, with a high estimate of 734.00 and a low estimate of 400.00. The median estimate represents a -2.74% decrease from the last price of 639.53.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.90%
Growthannually 9.08%


Growthquarterly -6.58%
Growthannually -3.47%
Key to the earnings and sales forecast charts.